These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17394136)

  • 1. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.
    Sugihara T; Sekine C; Nakae T; Kohyama K; Harigai M; Iwakura Y; Matsumoto Y; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2007 Apr; 56(4):1304-14. PubMed ID: 17394136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.
    Okiyama N; Sugihara T; Iwakura Y; Yokozeki H; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Aug; 60(8):2505-12. PubMed ID: 19644888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.
    Sugihara T; Okiyama N; Watanabe N; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2012 Aug; 64(8):2655-62. PubMed ID: 22392010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model.
    Okiyama N; Sugihara T; Oida T; Ohata J; Yokozeki H; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2012 Nov; 64(11):3741-9. PubMed ID: 22806443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
    Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
    J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
    Neumann J; Bilzer T
    Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis.
    Sugihara T; Okiyama N; Suzuki M; Kohyama K; Matsumoto Y; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2010 Oct; 62(10):3088-92. PubMed ID: 20583106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody].
    Ayabe M; Kawamoto M; Ijima H; Hino H; Shoji H
    Rinsho Shinkeigaku; 1997 Mar; 37(3):208-11. PubMed ID: 9217418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
    Englund P; Wahlström J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
    Arthritis Rheum; 2007 Jan; 56(1):372-83. PubMed ID: 17195241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice.
    Hasegawa H; Kawahata K; Mizoguchi F; Okiyama N; Miyasaka N; Kohsaka H
    Clin Exp Rheumatol; 2017; 35(4):593-597. PubMed ID: 28134083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
    Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
    Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of pathogenic T cells and autoantibodies in C-protein-induced autoimmune polymyositis.
    Matsumoto Y; Kohyama K; Park IK; Nakajima M; Hiraki K
    J Neuroimmunol; 2007 Oct; 190(1-2):90-100. PubMed ID: 17900708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advance in polymyositis and dermatomyositis research].
    Kohsaka H
    Nihon Rinsho; 2009 Mar; 67(3):523-8. PubMed ID: 19280927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.
    Kim J; Choi JY; Park SH; Yang SH; Park JA; Shin K; Lee EY; Kawachi H; Kohsaka H; Song YW
    Arthritis Res Ther; 2014 Jun; 16(3):R126. PubMed ID: 24939012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
    Lau AC; Duong TT; Ito S; Yeung RS
    Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-γ, but Not Interleukin-4, Suppresses Experimental Polymyositis.
    Yoshihashi-Nakazato Y; Kawahata K; Kimura N; Miyasaka N; Kohsaka H
    Arthritis Rheumatol; 2016 Jun; 68(6):1505-10. PubMed ID: 26815159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
    Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
    Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide.
    Okiyama N; Hasegawa H; Oida T; Hirata S; Yokozeki H; Fujimoto M; Miyasaka N; Kohsaka H
    Int Immunol; 2015 Jul; 27(7):327-32. PubMed ID: 25577193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.
    Jackaman C; Lew AM; Zhan Y; Allan JE; Koloska B; Graham PT; Robinson BW; Nelson DJ
    Int Immunol; 2008 Nov; 20(11):1467-79. PubMed ID: 18824504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.